Clinical Trials Directory

Trials / Unknown

UnknownNCT01006668

Sevoflurane Versus Propofol for Intubation in Neonatal Intensive Care

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
28 Days
Healthy volunteers
Not accepted

Summary

Endotracheal intubation is a painful and stressful procedure, which is associated with acute increases of blood pressure, intracranial pressure, bradycardia and hypoxemia with high morbidity. The aim of the study is to compare recovery time, efficacy and tolerance in a randomized controlled study, between sevoflurane and propofol for intubation in neonates in Neonatal Intensive Care Unit.

Detailed description

Background: Endotracheal intubation is a painful and stressful procedure, which is associated with acute increases of blood pressure, intracranial pressure, bradycardia and hypoxemia with hight morbidity. In 2001, in France more than 50% of intubations in neonates were performed without any premedication or anesthesia. The most frequently used anesthesias are based on benzodiazepine or opioids. Unfortunately, these treatments are responsible for respiratory and hemodynamic adverse effects. Recently, 2 new possibilities for anesthesia before intubation has been tested: propofol was better than association of morphine, succinylcholine and atropine and we shaw that inhaled sevoflurane was better than no treatment. The aim of the present study is to compare recovery time, efficacy and tolerance in a randomized controlled study, between sevoflurane and propofol for intubation in neonates in Neonatal Intensive Care Unit. Objectives: The objective of this study is to compare recovery time, efficacy and tolerance in a randomized controlled study, between sevoflurane and propofol for intubation of neonates. Methods: Prospective, controlled, randomized, monocentric study. Subjects: Neonates in neonatal intensive care requiring intubation. Evaluation criteria: Recovery time after intubation, facilitation of procedure, tolerance of treatment (mean arterial pressure, apnea).

Conditions

Interventions

TypeNameDescription
DRUGAdministration of sevofluraneAdministration of sevoflurane (SEVORANE) by inhalation until a maximal concentration of 4% of inspired gas.
DRUGAdministration of propofolAdministration of propofol (DIPRIVAN) by intravenous injection (1 mg/kg to turn over twice if necessary.

Timeline

Start date
2009-11-01
Primary completion
2014-11-01
First posted
2009-11-03
Last updated
2014-08-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01006668. Inclusion in this directory is not an endorsement.